Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Nov 16, 2015 yancopoulos george Officer Disposition (Non Open Market) 1,612 n/a
Dec 15, 2014 mccorkle douglas s Officer Automatic Sell 1,668 410.16 - 417.34
Dec 15, 2014 mccorkle douglas s Officer Option Execute 1,668 30.63
Aug 27, 2014 mccorkle douglas s Officer Option Execute 1,681 21.25 - 30.63
Sep 1, 2015 larosa joseph j Officer Option Execute 1,689 59.20
Mar 30, 2011 brown michael s Director Automatic Sell 1,691 44.35
Mar 17, 2011 gilman alfred g Director Sell 1,700 38.97
Dec 15, 2008 goldberg murray a Officer Option Execute 1,700 7.41
Nov 19, 2015 vagelos p roy Officer Disposition (Non Open Market) 1,731 n/a
Oct 7, 2010 brown michael s Director Automatic Sell 1,765 28.03
Dec 19, 2012 mccorkle douglas s Officer Automatic Sell 1,841 174.52 - 180.75
Dec 17, 2012 goldberg murray a Officer Option Execute 1,850 20.32
Mar 30, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,852 n/a
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Dec 16, 2015 mccorkle douglas s Officer Option Execute 1,921 52.03
Dec 16, 2015 powchik peter Officer Option Execute 1,921 52.03
Dec 16, 2015 stahl neil Officer Option Execute 1,921 52.03
Dec 16, 2015 van plew daniel p Officer Option Execute 1,921 52.03
Dec 16, 2015 yancopoulos george Officer Option Execute 1,921 52.03
Nov 17, 2014 goldberg murray a Officer Disposition (Non Open Market) 1,930 n/a
Showing 81-100 of 1029 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)